GAMBACORTI PASSERINI CARLO

Civettini, I., Malighetti, F., Villa, M., Crippa, V., Aroldi, A., Cavalca, F., et al. (2026). Prognostic Score for Myelodysplastic Syndromes Based on Molecular Evolution. NEJM EVIDENCE, 5(6), 1-13 [10.1056/evidoa2500124]. Dettaglio

Duca, F., Manghisi, B., Palasciano, A., Mochi, A., Parma, M., Greco, R., et al. (2026). DNMT3A Co-Mutation and Real-World Clinical Outcomes With Gilteritinib in FLT3-Mutated Acute Myeloid Leukaemia Across Molecular Subgroups. EJHAEM, 7(4) [10.1002/jha2.70374]. Dettaglio

Gambacorti-Passerini, C., Bassi, G., Bonfanti, S., Duca, F., Piazza, R., Lattuada, E., et al. (2025). Reconstructing CML guidelines for first line treatment from two different points of view. BLOOD CANCER JOURNAL, 15(1) [10.1038/s41408-025-01331-8]. Dettaglio

Frustaci, A., Zappaterra, A., Turri, G., Rossi, V., Deodato, M., Gambacorti‐passerini, C., et al. (2025). Pirtobrutinib is an Effective Salvage Treatment After Ibrutinib in Bing–Neel Syndrome. AMERICAN JOURNAL OF HEMATOLOGY, 100(10), 1878-1881 [10.1002/ajh.27759]. Dettaglio

Kogan, M., Alviano, A., Catalano, M., Casiraghi, A., Ghilardi, G., Rindone, G., et al. (2025). Remission of low-grade lymphomatoid granulomatosis with extensive pulmonary involvement following immune restoration via antiretroviral therapy in a newly diagnosed HIV patient. AIDS RESEARCH AND THERAPY, 22(1) [10.1186/s12981-025-00717-9]. Dettaglio